midodrine has been researched along with Blood Pressure, High in 13 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Midodrine, a drug used to treat symptomatic orthostatic hypotension, may cause or exacerbate supine hypertension." | 7.71 | Supine hypertension during general anesthesia in a patient taking midodrine. ( Chaimberg, KH; Travis, KW, 2002) |
| "The comparative effects of droxidopa and midodrine on standing systolic blood pressure (sSBP) and risk of supine hypertension in patients with neurogenic orthostatic hypotension (NOH) are unknown." | 4.98 | Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials. ( Chen, JJ; Dashtipour, K; Han, Y; Hauser, RA; Portillo, I; Tang, J, 2018) |
| "Midodrine, a drug used to treat symptomatic orthostatic hypotension, may cause or exacerbate supine hypertension." | 3.71 | Supine hypertension during general anesthesia in a patient taking midodrine. ( Chaimberg, KH; Travis, KW, 2002) |
| "Particularly debilitating is neurogenic orthostatic hypotension (nOH) caused by deficient neurotransmission of norepinephrine, which is the primary neurotransmitter released at sympathetic peripheral vascular nerve terminals in response to orthostatic stress." | 2.61 | Chemical pharmacotherapy for the treatment of orthostatic hypotension. ( Cheshire, WP, 2019) |
| "Fludrocortisone did not increase angiotensinogen in these mice, implying that the rise in angiotensinogen in the siRNA-treated rats must have depended on the liver, most likely reflecting diminished cleavage by renin." | 1.72 | Conventional Vasopressor and Vasopressor-Sparing Strategies to Counteract the Blood Pressure-Lowering Effect of Small Interfering RNA Targeting Angiotensinogen. ( Danser, AHJ; Daugherty, A; Foster, D; Garrelds, IM; Hoorn, EJ; Lu, HS; Mirabito Colafella, KM; Nioi, P; Ren, L; Uijl, E; van Veghel, R; Ye, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Uijl, E | 1 |
| Ye, D | 1 |
| Ren, L | 1 |
| Mirabito Colafella, KM | 1 |
| van Veghel, R | 1 |
| Garrelds, IM | 1 |
| Lu, HS | 1 |
| Daugherty, A | 1 |
| Hoorn, EJ | 1 |
| Nioi, P | 1 |
| Foster, D | 1 |
| Danser, AHJ | 1 |
| Wegner Wippel, C | 1 |
| Deshpande, H | 1 |
| Patwa, H | 1 |
| Peixoto, AJ | 1 |
| Cannom, DS | 1 |
| Chen, JJ | 1 |
| Han, Y | 1 |
| Tang, J | 1 |
| Portillo, I | 1 |
| Hauser, RA | 1 |
| Dashtipour, K | 1 |
| Cheshire, WP | 2 |
| Sadeghpour, M | 1 |
| Bunick, CG | 1 |
| Robinson, DM | 1 |
| Galan, A | 1 |
| Tigelaar, RE | 1 |
| Imaeda, S | 1 |
| Tanabe, N | 1 |
| Takane, K | 1 |
| Yokoyama, K | 1 |
| Tanno, Y | 1 |
| Yamamoto, I | 1 |
| Ohkido, I | 1 |
| Yokoo, T | 1 |
| Wong, LY | 1 |
| Wong, A | 1 |
| Robertson, T | 1 |
| Burns, K | 1 |
| Roberts, M | 1 |
| Isbister, GK | 1 |
| Lagi, A | 1 |
| Spini, S | 1 |
| Chaimberg, KH | 1 |
| Travis, KW | 1 |
| Achem, SR | 1 |
| Sandroni, P | 1 |
| Benarroch, EE | 1 |
| Wijdicks, EF | 1 |
3 reviews available for midodrine and Blood Pressure, High
| Article | Year |
|---|---|
Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
Topics: Antiparkinson Agents; Bayes Theorem; Blood Pressure; Droxidopa; Humans; Hypertension; Hypotension, O | 2018 |
Chemical pharmacotherapy for the treatment of orthostatic hypotension.
Topics: Blood Pressure; Comorbidity; Droxidopa; Humans; Hypertension; Hypotension, Orthostatic; Midodrine | 2019 |
Clinostatic hypertension and orthostatic hypotension.
Topics: Antihypertensive Agents; Autonomic Nervous System; Blood Pressure; Humans; Hypertension; Hypotension | 2010 |
10 other studies available for midodrine and Blood Pressure, High
| Article | Year |
|---|---|
Conventional Vasopressor and Vasopressor-Sparing Strategies to Counteract the Blood Pressure-Lowering Effect of Small Interfering RNA Targeting Angiotensinogen.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Fludrocortisone; Hypertension; Mice; Midod | 2022 |
Neurogenic orthostatic hypotension after treatment with sorafenib.
Topics: Humans; Hypertension; Hypotension, Orthostatic; Male; Midodrine; Sorafenib; Vascular Endothelial Gro | 2022 |
Management of coexistent neurogenic orthostatic hypotension and supine hypertension.
Topics: Accidental Falls; Central Nervous System Agents; Droxidopa; Drug Substitution; Female; Humans; Hyper | 2019 |
Midodrine-induced acute generalized exanthematous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Humans; Hypertension; Male; Middle Aged; Midodrine; Vaso | 2014 |
Dialysate temperature adjustment as an effective treatment for baroreflex failure syndrome in hemodialysis patient.
Topics: Aged; Baroreflex; Carotid Sinus; Cold Temperature; Dialysis Solutions; Dizziness; Droxidopa; Enteral | 2014 |
Severe Hypertension and Bradycardia Secondary to Midodrine Overdose.
Topics: Adrenergic alpha-1 Receptor Antagonists; Blood Pressure; Bradycardia; Drug Overdose; Female; Glasgow | 2017 |
Supine hypertension during general anesthesia in a patient taking midodrine.
Topics: Adult; Amputation, Surgical; Anesthesia, General; Blood Pressure; Diabetes Mellitus, Type 1; Humans; | 2002 |
Clinical history.
Topics: Blood Pressure; Chest Pain; Clonazepam; Female; Heart Rate; Humans; Hypertension; Incidence; Middle | 2004 |
Midodrine marketed for orthostatic hypotension.
Topics: Adrenergic alpha-Agonists; Humans; Hypertension; Hypotension, Orthostatic; Midodrine; Prodrugs | 1996 |
Caudate hemorrhage as a possible complication of midodrine-induced supine hypertension.
Topics: Aged; Caudate Nucleus; Cerebral Hemorrhage; Humans; Hypertension; Hypotension, Orthostatic; Male; Mi | 2001 |